###begin article-title 0
Identification of CIITA Regulated Genetic Module Dedicated for Antigen Presentation
###end article-title 0
###begin p 1
Current address: Regulatory Biology Laboratory, Salk Institute for Biological Studies, La Jolla, California, United States of America
###end p 1
###begin p 2
Conceived and designed the experiments: MK QS WR. Performed the experiments: MK QS. Analyzed the data: MK QS PS CS. Contributed reagents/materials/analysis tools: EL. Wrote the paper: MK QS PS CS WR.
###end p 2
###begin p 3
The class II trans-activator CIITA is a transcriptional co-activator required for the expression of Major Histocompatibility Complex (MHC) genes. Although the latter function is well established, the global target-gene specificity of CIITA had not been defined. We therefore generated a comprehensive list of its target genes by performing genome-wide scans employing four different approaches designed to identify promoters that are occupied by CIITA in two key antigen presenting cells, B cells and dendritic cells. Surprisingly, in addition to MHC genes, only nine new targets were identified and validated by extensive functional and expression analysis. Seven of these genes are known or likely to function in processes contributing to MHC-mediated antigen presentation. The remaining two are of unknown function. CIITA is thus uniquely dedicated for genes implicated in antigen presentation. The finding that CIITA regulates such a highly focused gene expression module sets it apart from all other transcription factors, for which large-scale binding-site mapping has indicated that they exert pleiotropic functions and regulate large numbers of genes.
###end p 3
###begin title 4
Author Summary
###end title 4
###begin p 5
Most mammalian transcription factors and transcriptional co-activators are believed to regulate the activities of numerous genes fulfilling multiple functions. This pleiotropic role has recently been confirmed directly for several individual factors by large-scale mapping studies aimed at generating comprehensive catalogues of their binding sites in the genome. Until now, all transcription factors, for which such studies have been performed, were found to regulate hundreds or even thousands of genes. We demonstrate, here, that the transcriptional co-activator CIITA (class II transactivator) is an exception to this rule. CIITA is a key regulator of the immune system because it controls the transcription of genes coding for Major Histocompatibility Complex (MHC) class II molecules, which are cell-surface molecules that present peptide antigens to T lymphocytes. To address the possibility that CIITA might exert more widespread functions, we have performed extensive genome-wide searches to establish a comprehensive list of CIITA-regulated genes. Surprisingly, we found that CIITA regulates only a small number of genes, most of which code for proteins implicated directly or indirectly in MHC-mediated antigen presentation. CIITA is thus remarkably dedicated for the regulation of a unique set of functionally related genes constituting a genetic module devoted to a single biological process.
###end p 5
###begin title 6
Introduction
###end title 6
###begin p 7
###xml 736 739 736 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Marson1">[1]</xref>
###xml 740 743 740 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Wei1">[5]</xref>
Most mammalian transcription factors are believed to activate numerous genes having diverse functions. Direct support for this pleiotropic nature of transcription factor function has been provided by techniques permitting the unbiased mapping of transcription factor binding sites in substantial segments of genomic DNA, whole chromosomes or entire genomes. These large scale location techniques rely on sequencing or microarray (chip) analysis of genomic DNA sequences that are enriched by chromatin immunoprecipitation (ChIP) experiments. To date, all transcription factors for which these methods have been applied were found to bind to numerous target genes, typically in the order of several hundred to several thousand per genome [1]-[5]. The past few years has witnessed a controversy about whether this general rule of pleiotropic function is also valid for the Major Histocompatibility Complex class II (MHC-II) gene transactivator CIITA (NM_000246).
###end p 7
###begin p 8
###xml 53 59 53 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MHC-II</italic>
###xml 107 115 107 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 164 167 164 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Steimle1">[6]</xref>
###xml 186 191 186 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIITA</italic>
###xml 466 469 466 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Steimle1">[6]</xref>
###xml 470 473 470 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Reith1">[7]</xref>
###xml 934 937 927 930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Reith1">[7]</xref>
###xml 938 941 931 934 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Ting1">[9]</xref>
###xml 1030 1035 1023 1028 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MHC-I</italic>
###xml 1042 1045 1035 1038 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Reith1">[7]</xref>
###xml 1046 1050 1039 1043 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Gobin1">[12]</xref>
###xml 776 782 <span type="species:ncbi:9606">humans</span>
CIITA was first established to be a key regulator of MHC-II genes because it was found to be mutated in an in vitro generated B cell line lacking MHC-II expression [6]. Mutations in the CIITA gene were next shown to be one of the causes of the Bare Lymphocyte Syndrome (BLS) (MIM number: 600005), a hereditary immunodeficiency disease characterized by the virtually complete absence of MHC-II expression and a significant reduction in MHC class I (MHC-I) expression [6],[7]. In accordance with these genetic findings, CIITA was subsequently shown to be a non-DNA-binding transcriptional co-activator that is essential for expression of the genes encoding the alpha and beta chains of all classical and non-classical MHC-II molecules (HLA-DR, HLA-DP, HLA-DQ, HLA-DM, HLA-DO in humans) as well the gene encoding the Invariant chain (Ii), an accessory molecule controlling intracellular transport and peptide loading of MHC-II molecules [7]-[9]. CIITA was also found to contribute, albeit to a lesser extent, to the transcription of MHC-I genes [7]-[12].
###end p 8
###begin p 9
###xml 118 121 118 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Reith1">[7]</xref>
###xml 184 189 184 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIITA</italic>
###xml 195 198 195 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Reith1">[7]</xref>
###xml 199 202 199 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Ting1">[9]</xref>
###xml 642 646 642 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Wong1">[13]</xref>
###xml 777 781 769 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Nagarajan1">[14]</xref>
###xml 878 882 870 874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Gourley1">[15]</xref>
###xml 883 887 875 879 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Gourley3">[18]</xref>
###xml 993 997 985 989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Yee1">[19]</xref>
###xml 998 1002 990 994 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Yee2">[20]</xref>
###xml 1143 1147 1127 1131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Zhu1">[21]</xref>
###xml 1148 1152 1132 1136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Xu1">[22]</xref>
###xml 1293 1297 1277 1281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Nagarajan1">[14]</xref>
###xml 63 71 <span type="species:ncbi:9606">patients</span>
###xml 153 157 <span type="species:ncbi:10090">mice</span>
###xml 633 638 <span type="species:ncbi:10090">mouse</span>
###xml 717 722 <span type="species:ncbi:9606">human</span>
###xml 864 869 <span type="species:ncbi:10090">mouse</span>
###xml 969 974 <span type="species:ncbi:10090">mouse</span>
###xml 1279 1284 <span type="species:ncbi:9606">human</span>
All clinical and immunological abnormalities documented in BLS patients can be explained by defects in MHC expression [7]. The same is true for knockout mice carrying mutations in the CIITA gene [7],[9]. The absence of other overt phenotypes suggested that CIITA is highly dedicated for the transcription of MHC genes. It therefore came as a major surprise when a growing number of reports suggested that CIITA can affect the expression of numerous genes involved in diverse functions within and outside the immune system. Microarray experiments identified the gene encoding Plexin-A1, which was reported to be activated by CIITA in mouse DC [13], and over 40 genes that were suggested to be up-regulated by CIITA in human B cells and interferon-gamma (IFNgamma) induced cells [14]. The genes encoding IL-4 and Fas ligand were proposed to be repressed by CIITA in mouse T cells [15]-[18]. Those encoding cathepsin E and IL-10 were suggested to be repressed by CIITA in mouse B cells and/or DC [19],[20] . The genes encoding collagen type I alpha2, tymidine kinase and cyclin D1 were proposed to be repressed by CIITA in IFNgamma induced cells [21],[22]. Finally, microarray experiments identified 16 genes of diverse functions that were proposed to be down-regulated by CIITA in human B cells [14]. Taken together, these reports suggested that CIITA has widespread functions extending beyond its well established role in the control of MHC expression.
###end p 9
###begin p 10
###xml 466 472 466 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MHC-II</italic>
###xml 474 479 474 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MHC-I</italic>
###xml 484 486 484 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ii</italic>
###xml 112 120 <span type="species:ncbi:9606">patients</span>
###xml 141 145 <span type="species:ncbi:10090">mice</span>
The notion that CIITA exerts pleiotropic functions was at odds with the highly specific defects observed in BLS patients and CIITA-deficient mice. To address this discrepancy we set out to define the complete set of CIITA target genes by performing genome-scale ChIP-chip experiments. Our results demonstrate that CIITA is remarkably dedicated for the regulation of genes implicated in MHC-II and MHC-I mediated antigen presentation. Outside of the well established MHC-II, MHC-I and Ii genes, only nine new target genes were identified, seven of which are known or likely to function in processes related to antigen presentation. The finding that CIITA regulates such a highly specialized genetic module sets it apart from all other transcription factors for which large scale mapping of binding sites has been performed.
###end p 10
###begin title 11
Results
###end title 11
###begin title 12
Strategies for Identifying CIITA Target Genes
###end title 12
###begin p 13
###xml 121 129 121 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000058-g001">Figure 1</xref>
###xml 221 230 221 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000058-g001">Figure 1A</xref>
###xml 232 236 232 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Reith2">[23]</xref>
###xml 333 338 333 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIITA</italic>
###xml 383 387 383 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Landmann1">[24]</xref>
###xml 509 514 509 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIITA</italic>
###xml 778 787 774 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000058-g001">Figure 1A</xref>
###xml 789 792 785 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Reith1">[7]</xref>
###xml 793 796 789 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Ting1">[9]</xref>
###xml 1001 1005 997 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Durand1">[25]</xref>
###xml 1006 1010 1002 1006 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Nekrep1">[29]</xref>
###xml 1066 1070 1062 1066 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Masternak2">[30]</xref>
###xml 1071 1075 1067 1071 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Beresford1">[33]</xref>
###xml 1117 1121 1113 1117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RFX5</italic>
###xml 1123 1128 1119 1124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RFXAP</italic>
###xml 1133 1139 1129 1135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RFXANK</italic>
Approaches for identifying novel target genes of CIITA were developed on the basis of its expression and mode of action (Figure 1). The pattern of CIITA expression dictates the cell type specificity of MHC-II expression (Figure 1A) [23]. B cells and immature dendritic cells (iDC) are MHC-II positive because they express CIITA. The CIITA gene is instead silenced in mature DC (mDC) [24]. Most non-hematopoietic cells are MHC-II negative because they lack CIITA. The latter can however be induced to activate CIITA expression by stimulation with IFNgamma. CIITA is recruited to its known target genes through protein-protein interactions with a transcription factor complex that assembles on a characteristic enhancer composed of four sequences called the S, X, X2 and Y boxes (Figure 1A) [7]-[9]. Regulatory factor X (RFX) - a trimeric factor containing three subunits called RFX5 (NM_000449), RFXAP (NM_000538) and RFXANK (NM_134440) - is an essential component of this transcription factor complex [25]-[29]. CIITA recruitment is abolished in RFX-deficient cells [30]-[33]. Like defects in CIITA, mutations in the RFX5, RFXAP and RFXANK genes give rise to the BLS disease (MIM number: 601863, 601861, 603200).
###end p 13
###begin title 14
ChIP-chip strategies used to identify target genes of CIITA.
###end title 14
###begin p 15
###xml 88 93 88 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIITA</italic>
###xml 379 385 375 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MHC-II</italic>
###xml 387 392 383 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MHC-I</italic>
###xml 1175 1182 1171 1178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRA</italic>
(A) Schematic representation of the expression and function of CIITA. Expression of the CIITA gene is regulated by three independent promoters - pI, pIII and pIV - that are activated in iDC, B cells and IFNgamma induced cells, respectively. pI is silenced after maturation of DC (mDC). CIITA is a non-DNA-binding co-activator that activates expression of its known target genes (MHC-II, MHC-I, Ii) by binding to a transcription factor complex that assembles on an enhancer consisting of S, X, X2 and Y sequences. Known CIITA target genes contain an S-Y enhancer typically situated less than 200 bp upstream of the transcription initiation site. The X-box-binding factor RFX is essential for CIITA recruitment. (B) Four ChIP-chip strategies were developed for identifying target genes of CIITA in B cells and iDC. Test probes generated from CIITA-ChIP samples obtained from Raji B cells and iDC were hybridized to NimbleGen promoter arrays. Control probes were prepared from input DNA or CIITA-ChIP samples derived from RJ2.2.5 cells, SJO cells or mDC. (C) Enrichment of known CIITA target sequences in CIITA-ChIP probes. Quantitative PCR was used to verify enrichment of the HLA-DRA promoter in the indicated test samples (black bars) relative to control samples (open bars). The approximate fold-enrichment is indicated. To estimate enrichment relative to input DNA we used a control sequence exhibiting only nonspecific CIITA association (background). The results show the mean and SD of 3 independent experiments (each performed with triplicate PCR measurements).
###end p 15
###begin p 16
###xml 114 123 114 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000058-g001">Figure 1B</xref>
###xml 1175 1182 1175 1182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRA</italic>
###xml 1246 1255 1246 1255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000058-g001">Figure 1C</xref>
###xml 341 346 <span type="species:ncbi:9606">human</span>
###xml 1057 1064 <span type="species:ncbi:9606">patient</span>
Based on the above, we devised genome-wide ChIP-chip approaches according to four different experimental designs (Figure 1B). In all four approaches, ChIP samples obtained with CIITA-specific antibodies were used to prepare probes that were hybridized in conjunction with control probes to microarrays carrying the promoter regions of 27434 human genes. The four strategies differed with respect to the cell type used to prepare the ChIP samples and the control probes to which they were compared. In the first strategy, CIITA-ChIP probes derived from the wild type B cell line Raji were compared with CIITA-ChIP probes derived from RJ2.2.5, a CIITA-deficient mutant of Raji. In the second strategy, CIITA-ChIP samples prepared from iDC were compared with CIITA-ChIP samples from mDC. In the third strategy, CIITA-ChIP probes derived from Raji were compared with input genomic DNA from Raji. In the fourth stratetgy, CIITA-ChIP probes derived from Raji were compared with CIITA-ChIP probes prepared from a cell line (SJO) derived from an RFX5-deficient BLS patient. In all four experimental settings, there is a robust enrichment of known CIITA target sequences, such as the HLA-DRA promoter, in the test samples relative to the control samples (Figure 1C).
###end p 16
###begin title 17
Validation of the ChIP-Chip Screens
###end title 17
###begin p 18
###xml 127 133 127 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MHC-II</italic>
###xml 135 137 135 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ii</italic>
###xml 142 147 142 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MHC-I</italic>
###xml 155 163 155 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000058-g002">Figure 2</xref>
###xml 165 172 165 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000058-t001">Table 1</xref>
###xml 174 183 174 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000058.s001">Figure S1</xref>
###xml 806 814 806 814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000058-g002">Figure 2</xref>
###xml 816 825 816 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000058.s002">Figure S2</xref>
###xml 963 970 951 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000058-t001">Table 1</xref>
###xml 1052 1077 1040 1065 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DOB, HLA-DPB, HLA-DMB</italic>
###xml 1082 1089 1070 1077 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DQA</italic>
###xml 1097 1104 1085 1092 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000058-t001">Table 1</xref>
###xml 1275 1282 1263 1270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRA</italic>
###xml 1288 1292 1276 1280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Krawczyk1">[32]</xref>
To validate our screening strategies we examined binding of CIITA to the promoters of well established target genes, including MHC-II, Ii and MHC-I genes (Figure 2, Table 1, Figure S1). Clear binding of CIITA - visualized as peaks in the test/control signal ratios - was observed in Raji B cells and iDC at positions corresponding to the S-Y enhancers of these genes. Despite some variability in the width and height of the peaks, binding of CIITA at the correct position was observed reproducibly in nine independent experiments using all four screening strategies. Binding signals were strong; test/control signal ratios typically ranged from a minimum of 6 to over 30 depending on the target gene and the experiment. Binding of CIITA was never observed at control genes that are not regulated by CIITA (Figure 2, Figure S2). The sensitivity of our ChIP-chip approach was high. The false-negative rate was only approximately5% at well-established target genes (Table 1). Furthermore, robust peaks were observed in all or most experiments even at the HLA-DOB, HLA-DPB, HLA-DMB and HLA-DQA genes (Table 1) despite the fact that CIITA binding signals observed at these genes in classical ChIP experiments are typically 10-20 fold lower than those observed at the prototypical HLA-DRA gene [32].
###end p 18
###begin title 19
Binding of CIITA to known target genes.
###end title 19
###begin p 20
###xml 24 31 24 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRA</italic>
###xml 33 41 33 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 43 50 43 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DMA</italic>
###xml 52 59 52 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DOA</italic>
###xml 61 63 61 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ii</italic>
###xml 68 73 68 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C</italic>
###xml 161 166 161 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAB4A</italic>
###xml 232 233 232 233 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 462 467 462 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C</italic>
Binding of CIITA to the HLA-DRA, HLA-DRB1, HLA-DMA, HLA-DOA, Ii and HLA-C genes is evident in the ChIP-chip experiments performed with Raji B cells and iDC. The RAB4A gene was used as negative control. Results are represented as log2 ratios between hybridization signals obtained with CIITA-ChIP probes from Raji and RJ2.2.5 (left column) or iDC and mDC (right column). Each dot corresponds to a single oligonucleotide on the array. The dotted line in the right HLA-C profile indicates a peak that was not reproduced in all experiments. The schematic maps show positions of the transcription start sites (arrows) and S-Y enhancers (grey boxes). The scale in Kb relative to the start site is provided below.
###end p 20
###begin title 21
Summary of ChIP-chip and classical ChIP experiments.
###end title 21
###begin p 22
###xml 246 247 246 247 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Results of independent CIITA-ChIP-chip experiments performed with NimbleGen promoter arrays: + signs indicate the presence of a peak in the signal ratios; the number of + signs refers to the quality of the peaks; +++ indicates strong signals (log2 ratio > 2) at four or more adjacent oligonucleotides or weaker signals at more than four adjacent oligonnucleotides; ++ indicates strong signals at three adjacent oligonucleotides or weaker signals at four adjacent oligonucleotides; + indicates strong signals at two adjacent oligonucleotides or weaker signals at three adjacent oligonucleotides.
###end p 22
###begin p 23
Results of classical CIITA-ChIP experiments: positive, confirmed binding; negative, absence of binding; nt, not tested.
###end p 23
###begin p 24
###xml 97 105 97 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000058-g002">Figure 2</xref>
###xml 333 343 333 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">discussion</xref>
Certain peaks exhibit a dip in CIITA binding at a position that coincides with the S-Y enhancer (Figure 2). These dips are likely to be artifacts because they generally concerned only a single oligonucleotide on the array, were not observed in all experiments and were not observed in experiments using high density microarrays (see discussion).
###end p 24
###begin title 25
Identification of New CIITA Target Genes
###end title 25
###begin p 26
###xml 215 236 215 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 479 486 479 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000058-t001">Table 1</xref>
###xml 648 655 648 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000058-t001">Table 1</xref>
###xml 780 788 780 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000058.s007">Table S1</xref>
To identify potential new targets of CIITA, we developed a procedure to screen for the presence of reproducible peaks in the test/control signal ratios obtained in multiple Raji/RJ2.2.5 and iDC/mDC comparisons (see Materials and Methods). Candidate genes were assigned a score on the basis of peak height, width and reproducibility. A score of 3 was assigned to the candidate genes at which peak quality and reproducibility were similar to those observed for known target genes (Table 1). A score of 2 was assigned to candidate genes for which peak quality and/or reproducibility were promising but significantly lower than for known target genes (Table 1). Finally a score of 1 was assigned to possible but unlikely candidates exhibiting only weak and poorly reproducible peaks (Table S1). The number of likely candidates was surprisingly low: scores of 3 and 2 were assigned, respectively, to only twelve and twenty genes.
###end p 26
###begin p 27
###xml 152 161 152 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000058-g003">Figure 3A</xref>
###xml 591 596 591 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAB4B</italic>
###xml 598 604 598 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM26</italic>
###xml 606 614 606 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLJ45422</italic>
###xml 616 624 616 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KIAA0841</italic>
###xml 626 630 626 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RFX5</italic>
###xml 632 638 632 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNF672</italic>
###xml 640 644 640 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TPP1</italic>
###xml 649 655 649 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYBPC2</italic>
###xml 689 694 689 694 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PSMD3</italic>
###xml 758 762 758 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRD2</italic>
###xml 767 773 767 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM14</italic>
###xml 982 990 982 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000058-g003">Figure 3</xref>
###xml 992 999 992 999 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000058-t001">Table 1</xref>
###xml 1001 1009 1001 1009 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000058.s007">Table S1</xref>
###xml 1390 1397 1390 1397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000058-t001">Table 1</xref>
To validate bona fide new target genes we screened the most promising candidates for binding of CIITA in Raji B cells by quantitative ChIP experiments (Figure 3A). All twelve score 3 candidates, sixteen score 2 candidates and a selection of the best score 1 candidates were tested. The primers used for real-time PCR analysis of the ChIP experiments were designed within the regions at which peaks were observed in the ChIP-chip experiments. Four score 2 candidates were not tested because suitable primers could not be designed. Binding of CIITA was confirmed for eight score 3 candidates (RAB4B, TRIM26, FLJ45422, KIAA0841, RFX5, ZNF672, TPP1 and MYBPC2) and only one score 2 candidate (PSMD3). Weaker binding was observed at two additional score 2 genes (BRD2 and TRIM14), but these were not studied further because signals were only 2-3 fold above background. No significant binding was evident at the remaining score 3 and score 2 genes, or at any of the tested score 1 genes (Figure 3, Table 1, Table S1). The finding that most of the score 3 candidates, only one of the score 2 candidates and none of the tested score 1 candidates are true targets of CIITA demonstrates the validity of our scoring procedure. These results also demonstrate that the specificity of our approach is greatest if peak reproducibility is chosen as the most critical parameter for predicting target genes (Table 1). Thus, among genes at which peaks are present in at least four out of five experiments (MHC-II and score 3 genes) less than 20% were found to be false positives, whereas the false positive rate increased dramatically among genes at which peaks were detected at only three out of five experiments (score 2 genes).
###end p 27
###begin title 28
Identification of novel target genes of CIITA.
###end title 28
###begin p 29
###xml 99 106 99 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRA</italic>
###xml 111 113 111 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ii</italic>
###xml 302 323 302 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 325 334 325 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000058.s007">Tables S1</xref>
###xml 339 341 339 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000058.s008">S2</xref>
###xml 418 425 418 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRA</italic>
###xml 782 790 782 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000058-g002">Figure 2</xref>
###xml 992 999 992 999 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRA</italic>
###xml 1001 1003 1001 1003 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ii</italic>
###xml 1114 1121 1114 1121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRA</italic>
(A) Binding of CIITA to the indicated genes was assessed in Raji B cells by quantitative ChIP. The HLA-DRA and Ii genes were used as positive controls. As negative control we used a sequence exhibiting only nonspecific CIITA association (background). Scores assigned to the candidate target genes (see Materials and Methods, Tables S1 and S2) are indicated above. Results are expressed relative to binding of CIITA at HLA-DRA, and show the mean and SD of 3 independent experiments (each performed with triplicate PCR measurements). Binding was deemed significant if it was greater than 2-fold above background. (B) Representative CIITA-binding profiles obtained in ChIP-chip experiments are provided for the nine new target genes validated in panel A. Results are represented as in Figure 2 for ChIP-chip experiments comparing Raji and RJ2.2.5 cells. (C) Binding of CIITA to the new target genes was confirmed by quantitative ChIP experiments performed with Raji and RJ2.2.5 cells. Positive (HLA-DRA, Ii) and negative (background) controls were as in panel A. Results are expressed relative to binding of CIITA at HLA-DRA in Raji, and show the mean and SD of 3 independent experiments (each performed with triplicate PCR measurements).
###end p 29
###begin p 30
###xml 92 101 92 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000058-g003">Figure 3B</xref>
###xml 186 192 186 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MHC-II</italic>
###xml 194 199 194 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MHC-I</italic>
###xml 204 206 204 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ii</italic>
###xml 292 301 292 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000058-g003">Figure 3B</xref>
###xml 307 315 307 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000058-g002">Figure 2</xref>
###xml 320 329 320 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000058.s001">Figure S1</xref>
Representative ChIP-chip profiles corresponding to binding of CIITA in Raji are provided in Figure 3B for the nine validated target genes. Peaks similar in quality to those found at the MHC-II, MHC-I and Ii genes are observed near the transcription initiation site of all nine genes (compare Figure 3B with Figure 2 and Figure S1).
###end p 30
###begin p 31
###xml 208 215 208 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRA</italic>
###xml 220 222 220 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ii</italic>
###xml 333 342 333 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000058-g003">Figure 3C</xref>
To further confirm the specificity of our quantitative ChIP experiments we compared occupation of the new targets by CIITA between Raji and its CIITA-deficient derivative RJ2.2.5. As observed for the control HLA-DRA and Ii genes, binding of CIITA is reduced to non-specific background levels in RJ2.2.5 at all nine new target genes (Figure 3C).
###end p 31
###begin p 32
###xml 282 286 282 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Scacheri1">[34]</xref>
###xml 632 636 632 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RFX5</italic>
###xml 638 643 638 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAB4B</italic>
###xml 645 650 645 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PSMD3</italic>
###xml 1048 1054 1048 1054 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM26</italic>
###xml 1056 1064 1056 1064 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLJ45422</italic>
###xml 1066 1074 1066 1074 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KIAA0841</italic>
###xml 1076 1082 1076 1082 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNF672</italic>
###xml 1084 1088 1084 1088 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TPP1</italic>
###xml 1093 1099 1093 1099 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYBPC2</italic>
To address the possibility that numerous true target genes might have been missed by our data analysis procedure we used two additional independent methods to analyze the same datasets. First, the windowing and threshold program ACME (Algorithm for Capturing Microarray Enrichment) [34] was used for peak detection, and significant peaks present in at least four out of five experiments were identified. In addition to MHC-II and related genes, this procedure identified only 17 potential new target genes (data not shown). Quantitative ChIP experiments performed with 11 of these showed that only 3 represented true CIITA targets (RFX5, RAB4B, PSMD3). The other 8 were found to be false positives that had been assigned scores of 3 (3 genes), 2 (2 genes) and 1 (3 genes) by our initial procedure. The remaining 6 candidates were not tested because visual inspection of their ChIP-chip peaks revealed that they were of very low quality and highly likely to correspond to false positive hits. Importantly, 6 of the validated new CIITA target genes (TRIM26, FLJ45422, KIAA0841, ZNF672, TPP1 and MYBPC2) were not picked up.
###end p 32
###begin p 33
###xml 88 108 88 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Material and Methods</xref>
###xml 210 211 210 211 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 419 424 419 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAB4B</italic>
###xml 426 432 426 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM26</italic>
###xml 434 442 434 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KIAA0841</italic>
###xml 444 448 444 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RFX5</italic>
###xml 450 456 450 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNF672</italic>
###xml 461 467 461 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYBPC2</italic>
###xml 680 688 680 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLJ45422</italic>
###xml 690 694 690 694 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TPP1</italic>
###xml 699 705 699 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYBPC2</italic>
As a second alternative approach we developed an unsupervised clustering procedure (see Material and Methods). This method grouped potential candidates into 8 groups on the basis of peak reproducibility and log2 signal ratios (data not shown). The two groups corresponding to the most likely targets contained only 12 and 29 genes respectively. 12 of these were MHC-II genes and 6 were among the new validated targets (RAB4B, TRIM26, KIAA0841, RFX5, ZNF672 and MYBPC2). Among the remaining 23 genes, 2 were found to be false positives by ChIP experiments and 22 were eliminated as good candidates by visual inspection of the peaks. Finally, 3 of the newly validated target genes (FLJ45422, TPP1 and MYBPC2) were again not singled out as likely candidates. In conclusion, neither alternative approach was superior to our original method with respect to specificity or sensitivity. More importantly, the alternative methods did not identify a large number of likely targets that were missed by our original procedure.
###end p 33
###begin title 34
Binding of CIITA to the New Targets in DC and IFNgamma Induced Cells
###end title 34
###begin p 35
###xml 137 146 137 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000058-g004">Figure 4A</xref>
###xml 148 155 148 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000058-t001">Table 1</xref>
###xml 337 346 337 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000058-g004">Figure 4B</xref>
###xml 377 384 377 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRA</italic>
###xml 389 391 389 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ii</italic>
###xml 441 450 441 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000058-g004">Figure 4B</xref>
Strong and reproducible peaks were also evident at the new target genes in ChIP-chip experiments comparing ChIP probes from iDC and mDC (Figure 4A, Table 1). We therefore performed quantitative ChIP experiments to measure binding of CIITA to the new targets in iDC. For eight of the new targets, significant binding was observed in iDC (Figure 4B). As observed for the control HLA-DRA and Ii genes, this binding was strongly reduced in mDC (Figure 4B).
###end p 35
###begin title 36
CIITA binds to the new target genes in DC and IFNgamma induced cells.
###end title 36
###begin p 37
###xml 150 158 150 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000058-g002">Figure 2</xref>
###xml 382 389 382 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRA</italic>
###xml 743 750 739 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRA</italic>
###xml 897 904 893 900 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRA</italic>
###xml 906 908 902 904 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ii</italic>
###xml 956 964 952 960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000058-g003">Figure 3</xref>
(A) Representative CIITA-binding profiles obtained for the new target genes in ChIP-chip experiments performed with DC. Results are represented as in Figure 2 for ChIP-chip experiments comparing iDC and mDC. (B) Binding of CIITA to the new target genes was confirmed by quantitative ChIP experiments performed with iDC and mDC. Results are expressed relative to binding of CIITA at HLA-DRA in iDC, and show the mean and SD of 3 independent experiments (each performed with triplicate PCR measurements). (C) Binding of CIITA to the new target genes was confirmed by quantitative ChIP experiments performed with Me67.8 melanoma cells stimulated for 0, 6 or 12 hours with IFNgamma. Results are expressed relative to the plateau level obtained at HLA-DRA in cells induced for 12 hours, and show the mean and SD of 3 independent experiments (each performed with triplicate PCR measurements). Positive (HLA-DRA, Ii) and negative (background) controls were as in Figure 3.
###end p 37
###begin p 38
###xml 80 89 76 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000058-g001">Figure 1A</xref>
###xml 310 314 298 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Rybtsova1">[35]</xref>
###xml 395 404 379 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000058-g004">Figure 4C</xref>
###xml 435 442 419 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRA</italic>
###xml 447 449 431 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ii</italic>
###xml 553 562 537 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000058-g004">Figure 4C</xref>
CIITA can be induced in most CIITA negative cells by stimulation with IFNgamma (Figure 1A). We therefore performed quantitative ChIP experiments to determine whether binding of CIITA to the new targets is induced by IFNgamma in a melanoma cell line exhibiting well documented IFNgamma induced CIITA expression [35]. IFNgamma induced occupation by CIITA was evident at all nine new target genes (Figure 4C). As observed for the control HLA-DRA and Ii genes, this occupation by CIITA is induced rapidly, reaching maximal levels by 6 hours of stimulation (Figure 4C).
###end p 38
###begin title 39
Recruitment of CIITA to the New Targets Is Dependent on RFX
###end title 39
###begin p 40
###xml 151 160 151 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000058-g005">Figure 5A</xref>
###xml 162 169 162 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000058-t001">Table 1</xref>
###xml 504 511 504 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRA</italic>
###xml 516 518 516 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ii</italic>
###xml 636 645 636 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000058-g005">Figure 5B</xref>
At all nine new target genes, strong and reproducible peaks were evident in ChIP-chip experiments comparing CIITA-ChIP probes from Raji and SJO cells (Figure 5A, Table 1). This suggested that recruitment of CIITA to the new genes is - as established for other known target genes - strictly dependent on binding of RFX. To verify this we performed quantitative ChIP experiments comparing binding of CIITA between Raji, RFX5-deficient SJO cells and RFXANK-deficient BLS1 cells. As observed for the control HLA-DRA and Ii genes, binding of CIITA is completely lost in SJO and BLS1 cells, indicating that it requires an intact RFX complex (Figure 5B).
###end p 40
###begin title 41
Recruitment of CIITA to the new target genes is dependent on binding of RFX.
###end title 41
###begin p 42
###xml 161 169 161 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000058-g002">Figure 2</xref>
###xml 357 364 357 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRA</italic>
###xml 664 671 664 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRA</italic>
###xml 947 954 947 954 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRA</italic>
(A) Representative CIITA binding profiles obtained for the new target genes in ChIP-chip experiments comparing Raji and SJO cells. Results are represented as in Figure 2. (B) Binding of CIITA to the new target genes was assessed by quantitative ChIP experiments performed with Raji, SJO and BLS1 cells. Results are expressed relative to binding of CIITA at HLA-DRA in Raji, and show the mean and SD of 3 independent experiments (each performed with triplicate PCR measurements). (C) Binding of RFX to the new target genes was assessed by quantitative ChIP experiments performed with Raji, RJ2.2.5 and SJO cells. Results are expressed relative to binding of RFX at HLA-DRA in Raji, and show the mean and SD of 3 independent experiments (each performed with triplicate PCR measurements). (D) Binding of RFX to the new target genes was assessed by quantitative ChIP experiments performed with iDC. Results are expressed relative to binding of RFX at HLA-DRA, and show the mean and SD of 3 independent experiments (each performed with triplicate PCR measurements). nd, not done.
###end p 42
###begin p 43
###xml 201 205 201 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Masternak2">[30]</xref>
###xml 206 210 206 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Masternak3">[31]</xref>
###xml 326 335 326 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000058-g005">Figure 5C</xref>
###xml 406 415 406 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000058-g005">Figure 5D</xref>
To document binding of RFX to the new target genes directly, we performed quantitative ChIP experiments with Raji, RJ2.2.5 and SJO cells. As shown previously for well established CIITA regulated genes [30],[31], binding of RFX to the new target genes is strong in Raji, unaffected in RJ2.2.5, but completely abolished in SJO (Figure 5C). Finally, RFX was also found to bind to the new target genes in iDC (Figure 5D) and IFNgamma induced cells (data not shown).
###end p 43
###begin p 44
###xml 16 20 16 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RFX5</italic>
###xml 22 27 22 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RFXAP</italic>
###xml 32 38 32 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RFXANK</italic>
###xml 361 371 361 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000058-g003">Figures 3B</xref>
###xml 376 378 376 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000058-g004">4A</xref>
The analysis of RFX5, RFXAP and RFXANK mRNA abundance by quantitative RT-PCR demonstrated that the level of RFX expression is very similar in Raji B cells and iDC (data not shown). This is consistent with the observation that the strength of CIITA binding observed in ChIP-chip experiments at validated target genes is very similar between Raji and DC (compare Figures 3B and 4A).
###end p 44
###begin title 45
CIITA Is Recruited to the New Targets via a Typical S-Y Enhancer
###end title 45
###begin p 46
###xml 165 171 165 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MHC-II</italic>
###xml 299 308 299 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000058-g006">Figure 6A</xref>
###xml 310 313 310 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Reith1">[7]</xref>
###xml 314 317 314 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Ting1">[9]</xref>
###xml 433 438 433 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAB4B</italic>
###xml 440 448 440 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLJ45422</italic>
###xml 450 456 450 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNF672</italic>
###xml 458 464 458 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYBPC2</italic>
###xml 466 470 466 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TPP1</italic>
###xml 475 480 475 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PSMD3</italic>
###xml 548 557 548 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000058-g006">Figure 6A</xref>
###xml 651 657 651 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM26</italic>
###xml 659 667 659 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KIAA0841</italic>
###xml 672 676 672 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RFX5</italic>
###xml 801 807 801 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM26</italic>
###xml 812 816 812 816 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RFX5</italic>
###xml 842 851 842 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000058-g006">Figure 6A</xref>
###xml 1101 1110 1101 1110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000058.s003">Figure S3</xref>
###xml 1194 1202 1194 1202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KIAA0841</italic>
The finding that recruitment of CIITA to the new target genes is dependent on binding of RFX prompted us to search for sequences resembling the S-Y enhancer. In all MHC-II genes, the S, X, X2 and Y boxes of the S-Y enhancer are highly conserved with respect to their order, orientation and spacing (Figure 6A) [7]-[9]. A similar tightly-constrained arrangement of S, X, X2 and Y sequences was evident in six of the new target genes (RAB4B, FLJ45422, ZNF672, MYBPC2, TPP1 and PSMD3) at positions lying within the region to which CIITA is recruited (Figure 6A). Homology to a complete S-Y motif was less evident in the remaining three new target genes (TRIM26, KIAA0841 and RFX5). Although these three genes do contain a well conserved X/X2 region, no obvious S element is evident and only two of them (TRIM26 and RFX5) have a Y-like sequence (Figure 6A). This prompted us to determine whether NF-Y actually binds to the new S-Y enhancers. Quantitative ChIP experiments performed with an NF-Y antibody confirmed that the new S-Y enhancers, including two of the imperfect ones, are indeed bound by NF-Y (Figure S3). The only gene to which binding of NF-Y was detected only very weakly is the one (KIAA0841) lacking a potential Y-like sequence.
###end p 46
###begin title 47
The new target genes contain RFX and CIITA dependent S-Y enhancers.
###end title 47
###begin p 48
###xml 43 50 43 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRA</italic>
###xml 553 560 553 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRA</italic>
###xml 625 632 625 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRA</italic>
###xml 739 746 739 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRA</italic>
###xml 931 938 931 938 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRA</italic>
(A) Alignment between the S-Y motif of the HLA-DRA gene and sequences found within the regions to which CIITA is recruited at the new target genes. Sequences corresponding to the S, X, X2 and Y elements are boxed. The dashed box indicates a pyrimidine (py) rich region generally found at the 5' end of the X box. Numbers indicate spacing in nucleotides between the S and py or X2 and Y sequences. S and Y sequences are only shown if homology is evident. (B) Transient transfections were performed with luciferase reporter gene constructs containing the HLA-DRA regulatory region or hybrid promoters in which the S-Y motif of HLA-DRA was replaced with the S-Y sequences from the indicated new target genes. A construct containing the basal HLA-DRA promoter lacking the S-Y module (min) was used as negative control. Constructs were transfected into Raji, RJ2.2.5 and SJO cells. Results are expressed relative to the activity of the HLA-DRA construct in Raji, and show the mean and SD of 3 independent experiments (each performed with triplicate luciferase measurements). (C) A mutation disrupting the X box was introduced into the constructs containing the new S-Y enhancers. Activities of the wild type (wt) and mutated (Xm) constructs were compared in Raji cells. Results are expressed relative to the activity of wt construct, and show the mean and SD of 3 independent experiments (each performed with triplicate luciferase measurements).
###end p 48
###begin p 49
###xml 158 165 158 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRA</italic>
###xml 235 244 235 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000058-g006">Figure 6A</xref>
###xml 302 309 302 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRA</italic>
###xml 433 442 433 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000058-g006">Figure 6B</xref>
###xml 670 677 670 677 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRA</italic>
###xml 1004 1013 1004 1013 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000058-g006">Figure 6C</xref>
###xml 1089 1098 1089 1098 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000058-g006">Figure 6C</xref>
###xml 1168 1173 1168 1173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAB4B</italic>
###xml 1173 1177 1173 1177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Krawczyk1">[32]</xref>
To determine whether the new S-Y motifs can function as RFX and CIITA dependent enhancers we generated reporter gene constructs in which the S-Y motif of the HLA-DRA promoter was replaced with the S-Y motifs from the new target genes (Figure 6A). The activity of these chimeric constructs, the control HLA-DRA construct and a construct driven by a minimal promoter lacking an S-Y module were assessed in Raji, RJ2.2.5 and SJO cells (Figure 6B). In Raji, the constructs containing the new S-Y motifs exhibited activities that were at least 20-fold greater than the basal activity of the minimal promoter and attained levels ranging from 25% to 40% of the activity of the HLA-DRA construct. This expression was abolished in RJ2.2.5 and SJO cells. These results confirm that the new S-Y motifs function as transcriptional enhancers regulated by RFX and CIITA. To confirm that the X box is a critical element of the new S-Y enhancers we performed reporter gene assays with constructs having a mutated X box (Figure 6C). The X box mutation strongly decreased activity of the new S-Y enhancers (Figure 6C). We have recently reported similar results for the new S-Y motif of RAB4B[32].
###end p 49
###begin title 50
Regulation of the New Target Genes by CIITA
###end title 50
###begin p 51
###xml 214 223 214 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000058-g007">Figure 7A</xref>
###xml 271 276 271 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAB4B</italic>
###xml 278 284 278 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM26</italic>
###xml 286 294 286 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLJ45422</italic>
###xml 296 304 296 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KIAA0841</italic>
###xml 306 310 306 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RFX5</italic>
###xml 312 318 312 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNF672</italic>
###xml 320 326 320 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYBPC2</italic>
###xml 331 335 331 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TPP1</italic>
###xml 465 472 465 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRA</italic>
###xml 545 550 545 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C</italic>
###xml 582 587 582 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MHC-I</italic>
###xml 673 676 673 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Reith1">[7]</xref>
###xml 677 681 677 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-vandenElsen1">[11]</xref>
To confirm that the novel target genes are regulated by CIITA we quantified their endogenous mRNA abundance by quantitative RT-PCR in RJ2.2.5 cells and in RJ2.2.5 cells complemented with a CIITA expression vector (Figure 7A). Expression of eight of the new target genes (RAB4B, TRIM26, FLJ45422, KIAA0841, RFX5, ZNF672, MYBPC2 and TPP1) was significantly reduced in RJ2.2.5. This reduction was not as strong as that observed for classical targets of CIITA, such as HLA-DRA. However, it was similar to or stronger than the reduction observed for HLA-C. The new targets thus resemble MHC-I genes in that their expression is modulated by, but not strictly dependent on, CIITA [7]-[11].
###end p 51
###begin title 52
The new target genes are regulated by CIITA in B cells and are induced by IFNgamma.
###end title 52
###begin p 53
###xml 653 660 649 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRA</italic>
###xml 665 670 661 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C</italic>
(A) mRNA levels for the new target genes were compared between RJ2.2.5 cells (open bars) and RJ2.2.5 cells complemented with a CIITA expression vector (black bars). Results are represented relative to the expression found in the complemented cells, and show the mean and SD of 3 independent experiments (each performed in triplicate PCR measurements). (B) mRNA levels for the indicated target genes were measured in Me67.8 cells induced with IFNgamma for 0, 12, 24 and 48 hours. Results are represented as fold induction relative to uninduced cells, and show the mean and SD of 3 independent experiments (each performed in triplicate PCR measurements). HLA-DRA and HLA-C were included as control CIITA-regulated genes.
###end p 53
###begin p 54
###xml 147 156 143 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000058-g007">Figure 7B</xref>
###xml 208 213 204 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAB4B</italic>
###xml 215 223 211 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLJ45422</italic>
###xml 225 231 221 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYBPC2</italic>
###xml 236 240 232 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RFX5</italic>
###xml 336 343 328 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRA</italic>
###xml 348 353 340 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C</italic>
###xml 429 436 421 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRA</italic>
###xml 486 491 478 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C</italic>
###xml 526 531 518 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MHC-I</italic>
###xml 642 645 630 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Reith1">[7]</xref>
###xml 646 650 634 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Gobin1">[12]</xref>
We next performed real-time RT-PCR experiments with melanoma cells to determine whether expression of the new target genes is induced by IFNgamma (Figure 7B). mRNA abundance for four of the new target genes (RAB4B, FLJ45422, MYBPC2 and RFX5) was increased by IFNgamma according to a time course similar to that observed for the control HLA-DRA and HLA-C genes. Although induction of the new target genes was not as strong as for HLA-DRA, it was similar in magnitude to the induction of HLA-C. The new targets thus behave like MHC-I genes in that they exhibit a significant level of basal expression prior to IFNgamma induced CIITA expression [7]-[12].
###end p 54
###begin title 55
Discussion
###end title 55
###begin p 56
###xml 130 136 130 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MHC-II</italic>
###xml 138 143 138 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MHC-I</italic>
###xml 148 150 148 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ii</italic>
###xml 1113 1121 <span type="species:ncbi:9606">patients</span>
###xml 1336 1344 <span type="species:ncbi:9606">patients</span>
###xml 1404 1412 <span type="species:ncbi:9606">patients</span>
We have used four ChIP-chip approaches to establish a list of genes regulated directly by CIITA in B cells and DC. In addition to MHC-II, MHC-I and Ii genes, only nine new bona fide target genes were discovered. The current number of genes that have been demonstrated to be regulated directly by binding of CIITA does therefore not exceed twenty five. At all of these genes, the recruitment of CIITA is strictly dependent on binding of RFX to an X box sequence situated near the promoter. In most cases, this X box is situated in a characteristic S-Y enhancer. One of the new target genes encodes the RFX5 subunit of RFX, indicating the existence of a positive feedback loop for enhancing CIITA recruitment. Finally, seven of the nine new target genes are known or likely to be implicated in cellular processes contributing to antigen presentation (see below). Taken together, these results show that CIITA is dedicated for the regulation of a remarkably compact and highly specialized gene expression module devoted to antigen presentation. This is consistent with the fact that all phenotypes documented in BLS patients can be attributed to defects in antigen presentation. Furthermore, the finding that CIITA recruitment is strictly dependent on RFX at all validated target genes is in agreement with the observation CIITA deficient patients can not be distinguished phenotypically from RFX-deficient patients.
###end p 56
###begin p 57
###xml 566 572 566 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL1A2</italic>
###xml 638 647 638 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000058.s004">Figure S4</xref>
###xml 652 661 652 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000058.s005">Figure S5</xref>
###xml 768 772 764 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Xu1">[22]</xref>
###xml 1467 1488 1463 1484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 1698 1702 1694 1698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Krawczyk2">[36]</xref>
###xml 1703 1707 1699 1703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Gomez1">[37]</xref>
###xml 1776 1784 1772 1780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000058.s008">Table S2</xref>
###xml 1786 1795 1782 1791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000058.s006">Figure S6</xref>
###xml 1351 1356 <span type="species:ncbi:9606">human</span>
Robust and reproducible binding of CIITA was observed at all previously known and newly validated target genes in nine independent ChIP-chip experiments. No other bona fide target genes were identified by any of the four strategies. Genes at which signals were weaker and less reproducible turned out to be false positives. This suggests that most target genes of CIITA have been identified. It is nevertheless possible that certain target genes have been missed. There could be additional targets in specific cell types. In this respect it may be relevant that the COL1A2 promoter was not found to be occupied by CIITA in B cells or DC (Figure S4 and Figure S5) although earlier ChIP experiments had suggested that CIITA regulates this gene in IFNgamma induced cells [22]. It is also possible that certain targets were missed for technical reasons. For example, the relevant CIITA associated sequences could be refractory to PCR amplification, hybridize inefficiently or have been excluded by the NimbleGen array design program. Finally, additional target genes could be controlled by distant CIITA-dependent enhancers that are situated outside of the 5 kb promoter regions present on the NimbleGen arrays. To address the latter possibility we performed ChIP-chip experiments using a high density array of our own design carrying the entire extended human MHC as well as other selected regions of interest, including several of the target genes identified here (see Materials and Methods). ChIP-chip experiments performed with Raji and DC confirmed binding of CIITA to all target genes present on the array but did not - with the exception of known enhancers found in the vicinity of MHC-II genes [36],[37] - lead to the identification of any novel intergenic binding sites (Table S2, Figure S6). This contrasts with the high density of STAT1, p53 and NF-kB binding sites found by ChIP-chip in chromosome 22, many of which are situated far from transcription start sites. Intergenic CIITA-binding sites do thus not appear to be frequent, although we can of course not exclude their existence in other regions of the genome.
###end p 57
###begin p 58
###xml 58 66 58 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KIAA0841</italic>
###xml 163 169 163 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNF672</italic>
###xml 246 250 246 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Kaczynski1">[38]</xref>
###xml 290 296 290 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNF672</italic>
###xml 459 465 459 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM26</italic>
###xml 470 478 470 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLJ45422</italic>
###xml 532 537 532 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAB4B</italic>
###xml 542 546 542 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RFX5</italic>
###xml 613 617 613 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RFX5</italic>
###xml 787 791 787 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Masternak2">[30]</xref>
###xml 792 796 792 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Beresford1">[33]</xref>
###xml 798 803 798 803 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAB4B</italic>
###xml 1003 1007 1003 1007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Pfeffer1">[39]</xref>
###xml 1377 1381 1377 1381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Groothuis1">[40]</xref>
###xml 1382 1386 1382 1386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Lazzarino1">[44]</xref>
###xml 1524 1528 1524 1528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Lazzarino1">[44]</xref>
###xml 1534 1540 1534 1540 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYBPC2</italic>
###xml 1542 1548 1542 1548 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM26</italic>
###xml 1550 1555 1550 1555 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PSMD3</italic>
###xml 1557 1561 1557 1561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TPP1</italic>
###xml 1566 1574 1566 1574 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLJ45422</italic>
###xml 1703 1711 1703 1711 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLJ45422</italic>
###xml 1792 1796 1792 1796 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TPP1</italic>
###xml 1826 1830 1826 1830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Golabek1">[45]</xref>
###xml 1910 1915 1910 1915 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PSMD3</italic>
###xml 2059 2063 2059 2063 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Kloetzel1">[46]</xref>
###xml 2065 2071 2065 2071 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYBPC2</italic>
###xml 2117 2121 2117 2121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Weber1">[47]</xref>
###xml 2239 2245 2239 2245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYBPC2</italic>
###xml 2333 2337 2333 2337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Flashman1">[48]</xref>
###xml 2824 2828 2824 2828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Vascotto1">[49]</xref>
###xml 2829 2833 2829 2833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Gordy1">[51]</xref>
###xml 2844 2850 2844 2850 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM26</italic>
###xml 2930 2934 2930 2934 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Meroni1">[52]</xref>
The functions of two of the new target genes are unknown. KIAA0841 encodes a protein containing no characteristic sequence motifs providing clues to its function. ZNF672 encodes a transcription factor belonging to the Kreuppel zinc-finger family [38]. However, the genes and functions that ZNF672 might regulate are unknown. For the remaining seven new target genes there is a known or potential link within antigen presentation by MHC-II or MHC-I molecules. TRIM26 and FLJ45422 are situated with the class I region of the MHC. For RAB4B and RFX5, a key role in antigen presentation has already been established. RFX5 plays a pivotal role in activating MHC-II expression because it encodes the largest DNA-binding subunit of RFX and is essential for recruiting CIITA to its target genes [30]-[33]. RAB4B encodes an isoform of the small GTPase RAB4. RAB4 is associated with early and recycling endosomes, and regulates recycling of membranes and proteins from these compartments back to the cell surface [39]. These recycling processes play important roles in various antigen presentation processes, including MHC-II restricted presentation of peptides derived from antigens internalized by receptor-mediated uptake in B cells, cross-presentation of endocytosed antigens by MHC-I molecules in DC and the presentation of intact proteins by DC to the antigen receptors of B cells [40]-[44]. RAB4 has been implicated directly in the MHC-II restricted presentation of antigens internalized by receptor-mediated uptake in B cells [44]. For MYBPC2, TRIM26, PSMD3, TPP1 and FLJ45422, a role in antigen presentation is suggested by the nature of the protein and/or the cellular processes in which they function. FLJ45422 encodes a protein of unknown function exhibiting similarity to MHC-I molecules. TPP1 encodes a lysosomal protease [45] that could influence the generation of peptides presented by MHC-II molecules. PSMD3 encodes a regulatory subunit of the proteasome, a large protease complex implicated in the generation of peptides presented by MHC-I molecules [46]. MYBPC2 encodes an immunoglobulin superfamily member [47] that can bind to myosin and filamentous actin, and modifies the actin-stimulated ATPase activity of myosin. Although MYBPC2 is expressed abundantly in muscle and is best known for its role in muscle contraction [48], it is also expressed at lower level in other cell types and its tight regulation by CIITA suggests that it could have additional functions in antigen presenting cells. Importantly, the actin cytoskeleton and/or actin-based myosin motors have been implicated in MHC-II trafficking and receptor-driven antigen presentation in B cells, the formation of immune synapses between antigen presenting cells and T cells, and antigen capture and presentation by MHC-I and MHC-II molecules in DC [49]-[51]. Finally, TRIM26 encodes a member of the tripartite motif (TRIM) family of ubiquitin E3 ligases [52]. Members of this family are implicated in diverse biological processes. They promote the ubiquitination of specific substrate proteins, thereby controlling their abundance by proteasome mediated degradation or their activity, intracellular trafficking or subcellular localization by proteasome-independent mechanisms. It is tempting to speculate that TRIM26 may regulate either the generation of specific antigenic peptides by the proteasome, or the abundance, activity or subcellular localization of specific proteins implicated in antigen presentation.
###end p 58
###begin p 59
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIITA</italic>
###xml 201 206 201 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIITA</italic>
###xml 255 259 255 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Reith2">[23]</xref>
###xml 260 264 260 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Holling1">[53]</xref>
###xml 433 438 433 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIITA</italic>
###xml 651 655 651 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-GarciaLora1">[54]</xref>
###xml 775 782 775 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1121 1127 1121 1127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNF672</italic>
###xml 1185 1190 1185 1190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAB4B</italic>
###xml 1264 1270 1264 1270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYBPC2</italic>
###xml 1375 1381 1375 1381 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM26</italic>
The CIITA gene is frequently silenced by epigenetic mechanisms in tumors. It has been proposed that the loss of MHC-II expression and/or a reduction in MHC-I expression resulting from the silencing of CIITA might allow tumors to evade immune surveillance [23],[53]. Our finding that CIITA is remarkably specific for genes implicated in antigen presentation is consistent with the hypothesis that the association between silencing of CIITA and tumorigenicity reflects a reduction in the antigen presentation capacity of the tumor cells. Although there is a well established link between the loss of MHC-I expression and escape from immune surveillance [54], it remains unclear how direct MHC-II mediated antigen presentation by tumor cells contributes to anti-tumor responses in vivo. Therefore, an alternative possibility that has to be kept in mind is that defective CIITA expression could represent a selective advantage for tumors because it contributes to the expression of non-MHC genes. In this respect, certain of the new target genes may be relevant. For instance, an altered transcription program due to reduced ZNF672 expression, deregulated vesicular traffic due to reduced RAB4B expression, perturbed intracellular actin-based transport due to reduced MYBPC2 expression, and altered ubiquitin-dependent degradation or regulation of specific proteins due to lower TRIM26 expression, could all contribute to the development of tumors.
###end p 59
###begin p 60
###xml 29 34 29 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAB4B</italic>
###xml 39 43 39 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TPP1</italic>
###xml 222 226 222 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Nagarajan1">[14]</xref>
###xml 228 233 228 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAB4B</italic>
###xml 330 334 330 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Krawczyk1">[32]</xref>
###xml 420 424 420 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Wong1">[13]</xref>
###xml 425 429 425 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Xu1">[22]</xref>
###xml 496 505 496 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000058.s004">Figure S4</xref>
###xml 657 666 657 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000058.s005">Figure S5</xref>
###xml 808 812 808 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Otten1">[55]</xref>
###xml 1053 1057 1053 1057 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Gourley2">[16]</xref>
###xml 1058 1062 1058 1062 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Sisk1">[17]</xref>
###xml 1063 1067 1063 1067 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Zhu1">[21]</xref>
###xml 1353 1357 1353 1357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Kodadek1">[56]</xref>
###xml 1377 1383 1377 1383 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM26</italic>
###xml 1388 1393 1388 1393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PSMD3</italic>
###xml 730 745 <span type="species:ncbi:10090">transgenic mice</span>
Two of the new target genes, RAB4B and TPP1, had been suggested to be regulated by CIITA in earlier studies. Both were among the genes that were found by microarray experiments to be downregulated in CIITA-deficient cells [14]. RAB4B was also singled out by a bioinformatic screen designed to identify genes containing S-Y motifs [32]. In contrast, more than 70 other genes suggested previously to be regulated by CIITA [13]-[22] were not found to be direct targets in our ChIP-chip experiments (Figure S4). For several of the most interesting candidates we were moreover unable to confirm binding of CIITA to their promoters by classical ChIP experiments (Figure S5). Finally, in a previous study using CIITA-deficient and CIITA-transgenic mice no direct control of these genes by CIITA could be documented [55]. The influence of CIITA on the expression of these genes is therefore likely to be mediated by indirect mechanisms. For several genes, an indirect mechanism involving sequestration of the general co-activator CBP by CIITA has been proposed [16],[17],[21]. Certain of the genes could be regulated by one of the two transcription factors - RFX5 and ZNF672 - shown here to be controlled by CIITA. Finally, there is growing evidence that ubiquitination and regulatory subunits of the proteasome can play key roles in transcriptional regulation [56]. The modulation of TRIM26 and PSMD3 expression by CIITA could thus have indirect impacts on the transcription of certain genes.
###end p 60
###begin p 61
###xml 334 337 334 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Marson1">[1]</xref>
###xml 506 509 506 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Hartman1">[2]</xref>
###xml 510 513 510 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Euskirchen1">[3]</xref>
###xml 588 591 588 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Cawley1">[4]</xref>
###xml 661 664 661 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Wei1">[5]</xref>
###xml 1279 1283 1279 1283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Krawczyk1">[32]</xref>
###xml 1784 1788 1784 1788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Ting2">[57]</xref>
###xml 1789 1793 1789 1793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Martinon1">[59]</xref>
###xml 322 327 <span type="species:ncbi:10090">mouse</span>
###xml 435 440 <span type="species:ncbi:9606">human</span>
###xml 648 653 <span type="species:ncbi:9606">human</span>
The remarkably focused role of CIITA emphasized here contrasts with results derived from large-scale binding studies for other transcription factors. Good illustrations are provided by Foxp3, Stat1, cMyc and p53. Over 1000 Foxp3 target genes were identified by scanning for binding sites in the promoter regions of 16'000 mouse genes [1]. Large scale mapping of Stat1 binding sites in chromosome 22 or selected (ENCODE) regions of the human genome have pointed to hundreds if not thousands of target genes [2],[3]. More than 300 cMyc target sites were identified in chromosomes 21 and 22 [4]. Finally, p53 binds to at least 500 target sites in the human genome [5]. Similar large numbers of targets have been reported for all other transcription factors for which large-scale binding studies have been reported. The high degree of specificity observed here for CIITA is thus unprecedented. Why CIITA presents this unique degree of specificity is unknown. One explanation may reside in the finding that CIITA recruitment appears to be strictly dependent on the assembly of a well-defined multifactor enhanceosome complex on a relatively large (65-70 bp) composite regulatory module (the S-Y motif) that is tightly constrained with respect to its sequence content and architecture [32]. Such S-Y modules are likely to be much less frequent in the genome than binding sites for individual transcription factors. A second explanation may lie in the fact that CIITA has quite an unusual origin for a nuclear transcription factor. It is the only transcriptional activator belonging to the mammalian nucleotide-binding domain and leucine-rich repeat (NLR) containing family, a large group of proteins exerting cytoplasmic functions implicated in cell death, inflammation and innate immunity [57]-[59]. The ability to activate transcription of a specific set of genes in the adaptive immune system may represent a recently evolved specialization acquired by an ancestral NLR protein originally having a completely different cytoplasmic function.
###end p 61
###begin title 62
Materials and Methods
###end title 62
###begin title 63
Cells
###end title 63
###begin p 64
###xml 117 121 117 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Krawczyk1">[32]</xref>
###xml 148 152 148 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Rybtsova1">[35]</xref>
###xml 386 390 382 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Landmann1">[24]</xref>
###xml 221 225 <span type="species:ncbi:9913">calf</span>
###xml 311 316 <span type="species:ncbi:9606">Human</span>
Raji, BLS1, SJO and RJ2.2.5 B cells, RJ2.2.5 cells complemented with an expression vector encoding CIITA isoform III [32] and Me67.8 melanoma cells [35] were cultured in RPMI + Glutamax medium complemented with 10% fetal calf serum and antibiotics. Me67.8 cells were induced with 200U/ml IFNgamma (Invitrogen). Human monocyte-derived DC were generated and matured with LPS as described [24].
###end p 64
###begin title 65
Chromatin Immunoprecipitation (ChIP)
###end title 65
###begin p 66
###xml 89 93 89 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Masternak2">[30]</xref>
###xml 94 98 94 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Masternak3">[31]</xref>
###xml 189 197 189 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000058.s009">Table S3</xref>
ChIP experiments were performed as described using antibodies specific for CIITA and RFX [30],[31] or NF-Y (Diagenode). Results were quantified by real-time PCR using the primers listed in Table S3. PCR was performed using the iCycler iQ Real-Time PCR Detection System (Biorad) and a Sybr-Green-based kit for quantitative PCR (iQ Supermix Biorad).
###end p 66
###begin title 67
ChIP-Chip Experiments
###end title 67
###begin p 68
###xml 81 88 81 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRA</italic>
###xml 1078 1083 <span type="species:ncbi:9606">human</span>
###xml 1196 1201 <span type="species:ncbi:9606">human</span>
CIITA-ChIP samples were verified by quantitative PCR to assess the enrichment of HLA-DRA sequences. DNA extracted from the ChIP samples were blunted for 30 minutes at 72degreesC with 3U of Pfu polymerase (Promega) and phosphorylated with T4 Polynucleotide kinase (New England Biolabs). 120 pmoles of adaptors, consisting of annealed oligonucleotides A (5'-GCGGTGACCCGGGAGATCTGAATTC-3') and B (5'-GAATTCAGATC-3'), were ligated to the DNA by overnight incubation at 16degreesC with 2000U of T4 DNA ligase (New England Biolabs). Two rounds of PCR amplification with oligonucleotide A were performed using 1.25U of Taq polymerase (New England Biolabs) and 0.025U of PfuTurbo polymerase (Stratagene). The cycle used was: 1 X (2' at 55degreesC, 5' at 72degreesC, 2' at 95degreesC), 28 X (1' at 95degreesC, 1' at 60degreesC, 2' at 72degreesC), 5' at 72degreesC. 4 microg of each DNA were purified and sent to NimbleGen for probe preparation and hybridization to arrays carrying the 5 kb promoter regions (approximately -4 kb to +1 kb relative to the transcription start site) of 27434 human genes, or to a custom array of our own design. The latter carries all unique sequences from the entire extended human MHC (7.7 Mb on chromosome 6, genomic coordinates 26.1 Mb to 33.8 Mb on hg17) as well as a number of other selected regions (total of 0.9 Mb), including several of the target genes identified here. These genomic regions are covered at high density with overlapping Tm-matched oligonucleotides (approximately50 bp long) spaced such that their 5' ends are situated approximately10 bp apart.
###end p 68
###begin title 69
Analysis of ChIP-Chip Data
###end title 69
###begin p 70
###xml 1953 1954 1953 1954 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2557 2558 2557 2558 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Data sets from five independent experiments (three Raji/RJ2.2.5 and two iDC/mDC comparisons) were analyzed with SignalMap software (NimbleGen). Positive peaks in the test/control signal ratios were calculated using a 500 base-pair sliding window and a cut-off that was deliberately set at a very low value (5% of maximum) to minimize the risk of eliminating weak peaks. This generated a large number of potential peaks (11262, 13322 and 15980 in the three Raji/RJ2.2.5 experiments, 13017 and 11795 in the two iDC/mDC experiments. The following procedure was then used to identify peaks present reproducibly in the five experiments. First, all peaks found in the five experiments were merged into a single list and sorted according to their genomic midpoint coordinates. A sliding window of five consecutive peaks was then used to identify genes exhibiting a peak in each of the five experiments. For these genes, the distance was calculated between the midpoints of the first and fifth peak and the list of these genes was then resorted according to these calculated peak proximities. Since the likelihood that peaks detected in different experiments correspond to the same binding site will increase with increased peak proximity, candidates with the smallest distance values between peaks were considered to be the most likely candidates. Similar algorithms were used to identify peaks present in only four or three of the five experiments. Finally, to avoid the risk of eliminating target genes because of a threshold difference between B cells and DC, all genes exhibiting closely superposable peaks in only the three Raji/RJ2.2.5 experiments or only the two iDC/mDC experiments were retained as candidates. Peaks for approximately 500 candidate genes identified by this procedure were re-examined visually and assigned a score based on reproducibility, width and strength of the signals. A score of 3 was assigned to genes where strong signals (log2 ratios exceeding 2) were spread over at least 400 base-pairs and were present in at least four experiments. A score of 2 was assigned to genes where strong signals were present in at least three experiments, or when weaker or narrower peaks were present in four or five experiments. A score of 1 was assigned to genes where three experiments exhibited weak signals or when signals were detected in only two experiments. A score of 0 was assigned to genes that did not meet the above criteria. To simplify representation of the results in the Figures, negative test/control signal ratios were set at log2  =  0.
###end p 70
###begin p 71
###xml 100 104 100 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Scacheri1">[34]</xref>
###xml 651 652 651 652 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 732 733 732 733 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 899 900 899 900 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1124 1128 1124 1128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Jaccard1">[60]</xref>
###xml 1359 1363 1359 1363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Kaufman1">[61]</xref>
###xml 1540 1544 1540 1544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Rousseeuw1">[62]</xref>
Two alternative approaches were also used to analyze the ChIP-chip data. One was a published method [34]. The second consisted of the following unsupervised approach. Peaks from the three Raji/RJ2.2.5 and two iDC/mDC experiments were pooled together, sorted by chromosome, midpoint coordinate and experiment, and considered to correspond to the same binding site if their distance was < 750 bp. Peaks that were only positive in 1 or 2 experiments were excluded from the following steps. To identify groups in the remaining peaks, they were represented as 4 bit binary vectors with the first 2 bits representing the number of peaks with significant log2 ratios and the last 2 bits representing the number of positive experiments. Log2 ratios were considered significant if their values were above 0.66, which corresponds to the quantile for a probability of 0.95 calculated on the complete set of log2 ratios determined over all experiments and peaks. Since the binary variables are asymmetric, a distance matrix between any pair of peaks represented by the rows of the binary matrix is calculated using the Jaccard distance [60]. This distance measure ranges from 0 (closely related peaks) to 1 (unrelated peaks). The resulting distance matrix was then used to determine the number of groups (partitions) using the PAM (Partitioning Around Medoids) algorithm [61]. Based on the above distance matrix, this algorithm calculates all possible partitions ranging from 2 to n-1 subgroups. For each partition the overall average silhouette width [62] is calculated and the partition that maximizes it is considered optimal.
###end p 71
###begin title 72
Plasmids and Reporter Gene Assays
###end title 72
###begin p 73
###xml 51 58 51 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRA</italic>
###xml 99 103 99 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Masternak3">[31]</xref>
###xml 130 144 130 144 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">AAGCTACCACTCGT</named-content>
###xml 187 191 187 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Krawczyk1">[32]</xref>
S-Y motifs were amplified by PCR and cloned in the HLA-DRA luciferase plasmid described previously [31]. The X box was altered to AAGCTACCACTCGT by site directed mutagenesis as described [32]. This mutation has a major impact on the activity of known S-Y enhancers. Transfections were done by electroporation. Dual luciferase reporter gene assays were performed according to instructions from the manufacturer (Promega).
###end p 73
###begin title 74
mRNA Quantification
###end title 74
###begin p 75
###xml 57 61 57 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000058-Masternak3">[31]</xref>
###xml 132 140 132 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000058.s010">Table S4</xref>
RNA extraction and cDNA synthesis were done as described [31]. Quantification was done by real-time PCR using the primers listed in Table S4. Results were normalized using 18S rRNA. Results were confirmed with several primer pairs.
###end p 75
###begin title 76
Supporting Information
###end title 76
###begin p 77
###xml 68 75 68 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRA</italic>
###xml 91 99 91 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 120 127 120 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DMA</italic>
###xml 294 295 294 295 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 575 582 575 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRA</italic>
###xml 628 635 628 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DMA</italic>
CIITA binding profiles are shown for three well known target genes, HLA-DRA (left column), HLA-DRB1 (middle column) and HLA-DMA (right column). The ChIP-chip profiles are derived from three Raji/RJ2.2.5, one Raji/input, three Raji/SJO and two iDC/mDC experiments. Results are represented as log2 ratios between the hybridization signals obtained with the test probes (CIITA-ChIP samples from Raji or iDC) and the control probes (input DNA or CIITA-ChIP samples from RJ2.2.5, SJO or mDC). Each dot corresponds to a single oligonucleotide on the array. The dotted lines in the HLA-DRA profile of the Raji/input experiment and the HLA-DMA profile of the third Raji/SJO experiment indicate sporadic peaks probably representing LM-PCR amplification artifacts. The schematic maps above the profiles show positions of the transcription start sites (arrows) and S-Y enhancers (grey boxes). The scale in Kb relative to the transcription start site is provided below.
###end p 77
###begin p 78
(0.52 MB PDF)
###end p 78
###begin p 79
Click here for additional data file.
###end p 79
###begin p 80
###xml 51 56 51 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 58 62 58 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACTB</italic>
###xml 64 69 64 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTPRC</italic>
###xml 71 75 71 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD19</italic>
###xml 77 82 77 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ITGAX</italic>
###xml 88 92 88 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LY75</italic>
###xml 289 290 289 290 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 584 588 584 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACTB</italic>
###xml 593 597 593 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LY75</italic>
ChIP-chip results are shown for six control genes (GAPDH, ACTB, PTPRC, CD19, ITGAX, and LY75) that are not regulated by CIITA. Representative profiles from Raji/RJ2.2.5 (left column), iDC/mDC (middle column) and Raji/SJO (right column) experiments are shown. Results are represented as log2 ratios between the hybridization signals obtained with the test probes (CIITA-ChIP samples from Raji or iDC) and the control probes (CIITA-ChIP samples from RJ2.2.5, mDC or SJO). Each dot corresponds to a single oligonucleotide on the array. The dotted lines in the iDC/mDC profiles shown for ACTB and LY75 indicate sporadic peaks probably representing LM-PCR amplification artifacts. The scale in Kb relative to the transcription start site is provided below.
###end p 80
###begin p 81
(0.40 MB PDF)
###end p 81
###begin p 82
Click here for additional data file.
###end p 82
###begin p 83
###xml 176 183 176 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRA</italic>
Binding of NF-Y to the indicated new target genes was assessed by quantitative ChIP experiments performed with Raji cells. Results are expressed relative to binding of NF-Y at HLA-DRA. As negative control we used a sequence exhibiting only nonspecific CIITA association (background). Results show the mean and SD of 2 independent experiments (each performed with triplicate PCR measurements).
###end p 83
###begin p 84
(0.01 MB PDF)
###end p 84
###begin p 85
Click here for additional data file.
###end p 85
###begin p 86
###xml 45 51 45 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL1A2</italic>
###xml 53 58 53 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EIF3I</italic>
###xml 60 65 60 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FASLG</italic>
###xml 67 70 67 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL4</italic>
###xml 72 77 72 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KPNA6</italic>
###xml 79 84 79 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RBBP4</italic>
###xml 86 90 86 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">YARS</italic>
###xml 96 102 96 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLXNA1</italic>
###xml 313 314 313 314 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
ChIP-chip results are shown for eight genes (COL1A2, EIF3I, FASLG, IL4, KPNA6, RBBP4, YARS, and PLXNA1) previously suggested to be regulated by CIITA. Representative profiles from Raji/RJ2.2.5 (left column), iDC/mDC (middle column) and Raji/SJO (right column) experiments are shown. Results are represented as log2 ratios between the hybridization signals obtained with the test probes (CIITA-ChIP samples from Raji or iDC) and the control probes (CIITA-ChIP samples from RJ2.2.5, mDC or SJO). Each dot corresponds to a single oligonucleotide on the array. The scale in Kb relative to the transcription start site is provided below.
###end p 86
###begin p 87
(0.42 MB PDF)
###end p 87
###begin p 88
Click here for additional data file.
###end p 88
###begin p 89
###xml 24 27 24 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL4</italic>
###xml 29 34 29 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FASLG</italic>
###xml 36 41 36 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KPNA6</italic>
###xml 43 47 43 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">YARS</italic>
###xml 49 54 49 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EIF31</italic>
###xml 56 62 56 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLXNA1</italic>
###xml 64 69 64 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RBBP4</italic>
###xml 75 81 75 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL1A2</italic>
###xml 237 244 237 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRA</italic>
###xml 367 373 367 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COL1A2</italic>
Binding of CIITA to the IL4, FASLG, KPNA6, YARS, EIF31, PLXNA1, RBBP4, and COL1A2, genes was assessed by quantitative ChIP experiments performed with Raji (R) and RJ2.2.5 (RJ) cells. Results are expressed relative to binding of CIITA at HLA-DRA in Raji. As negative control we used a sequence exhibiting only nonspecific CIITA association (background). Two different COL1A2 primer pairs were tested. Results show the mean of triplicate PCR measurements obtained for a representative experiment.
###end p 89
###begin p 90
(0.01 MB PDF)
###end p 90
###begin p 91
Click here for additional data file.
###end p 91
###begin p 92
###xml 128 135 128 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRA</italic>
###xml 137 144 137 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DMA</italic>
###xml 146 154 146 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FLJ45422</italic>
###xml 160 166 160 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM26</italic>
###xml 284 285 284 285 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 607 614 607 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRA</italic>
###xml 816 823 816 823 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRA</italic>
CIITA-ChIP-chip experiments performed with a high density custom array. (A) Representative CIITA binding profiles are shown for HLA-DRA, HLA-DMA, FLJ45422, and TRIM26 (top four profiles) and for candidate distant sequences A and B (bottom two profiles). Results are represented as log2 ratios between the hybridization signals obtained with CIITA-ChIP samples from Raji and RJ2.2.5. The scale in Kb relative to the transcription start site (arrows) is provided for the four genes. For the potential distant binding sites the nucleotide coordinates on chromosome 6 are indicated. (B) Binding of CIITA to the HLA-DRA gene and to the two potential binding sites A and B were assessed by quantitative ChIP experiments performed with Raji (R) and RJ2.2.5 (RJ) cells. Results are expressed relative to binding of CIITA at HLA-DRA in Raji. As negative control we used a sequence exhibiting only nonspecific CIITA association (background).
###end p 92
###begin p 93
(0.05 MB PDF)
###end p 93
###begin p 94
Click here for additional data file.
###end p 94
###begin p 95
Score 1 genes identified by CIITA-ChIP-chip experiments.
###end p 95
###begin p 96
(0.09 MB PDF)
###end p 96
###begin p 97
Click here for additional data file.
###end p 97
###begin p 98
ChIP-chip experiments performed with a custom high-density MHC array.
###end p 98
###begin p 99
(0.10 MB PDF)
###end p 99
###begin p 100
Click here for additional data file.
###end p 100
###begin p 101
Primer sequences used for ChIP.
###end p 101
###begin p 102
(0.01 MB PDF)
###end p 102
###begin p 103
Click here for additional data file.
###end p 103
###begin p 104
Primer sequences used for real-time RT-PCR.
###end p 104
###begin p 105
(0.08 MB PDF)
###end p 105
###begin p 106
Click here for additional data file.
###end p 106
###begin p 107
We are grateful to Michel Strubin, and to all members of the laboratory, for constructive discussions. We are grateful to Celine Delucinge Vivier and Patrick Descombes for help with bioinformatic analysis of the ChIP-chip data, and to Sean Davis for providing us with the ACME software.
###end p 107
###begin title 108
References
###end title 108
###begin article-title 109
Foxp3 occupancy and regulation of key target genes during T-cell stimulation.
###end article-title 109
###begin article-title 110
Global changes in STAT target selection and transcription regulation upon interferon treatments.
###end article-title 110
###begin article-title 111
Mapping of transcription factor binding regions in mammalian cells by ChIP: comparison of array- and sequencing-based technologies.
###end article-title 111
###begin article-title 112
###xml 61 66 <span type="species:ncbi:9606">human</span>
Unbiased mapping of transcription factor binding sites along human chromosomes 21 and 22 points to widespread regulation of noncoding RNAs.
###end article-title 112
###begin article-title 113
###xml 62 67 <span type="species:ncbi:9606">human</span>
A global map of p53 transcription-factor binding sites in the human genome.
###end article-title 113
###begin article-title 114
Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency.
###end article-title 114
###begin article-title 115
The bare lymphocyte syndrome and the regulation of MHC expression.
###end article-title 115
###begin article-title 116
Transcriptional regulation of the MHC class II antigen presentation pathway.
###end article-title 116
###begin article-title 117
Genetic control of MHC class II expression.
###end article-title 117
###begin article-title 118
Induction of MHC class I expression by the MHC class II transactivator CIITA.
###end article-title 118
###begin article-title 119
Regulation of MHC class I and II gene transcription: differences and similarities.
###end article-title 119
###begin article-title 120
The RFX complex is crucial for the constitutive and CIITA-mediated transactivation of MHC class I and beta2-microglobulin genes.
###end article-title 120
###begin article-title 121
CIITA-regulated plexin-A1 affects T-cell-dendritic cell interactions.
###end article-title 121
###begin article-title 122
Modulation of gene expression by the MHC class II transactivator.
###end article-title 122
###begin article-title 123
A novel role for the major histocompatibility complex class II transactivator CIITA in the repression of IL-4 production.
###end article-title 123
###begin article-title 124
Cutting edge: the class II transactivator prevents activation-induced cell death by inhibiting Fas ligand gene expression.
###end article-title 124
###begin article-title 125
MHC class II transactivator inhibits IL-4 gene transcription by competing with NF-AT to bind the coactivator CREB binding protein (CBP)/p300.
###end article-title 125
###begin article-title 126
###xml 37 41 <span type="species:ncbi:10090">mice</span>
Aberrant expression of Fas ligand in mice deficient for the MHC class II transactivator.
###end article-title 126
###begin article-title 127
Cathepsin E: a novel target for regulation by class II transactivator.
###end article-title 127
###begin article-title 128
Enhanced production of IL-10 by dendritic cells deficient in CIITA.
###end article-title 128
###begin article-title 129
A 36-amino-acid region of CIITA is an effective inhibitor of CBP: novel mechanism of gamma interferon-mediated suppression of collagen alpha(2)(I) and other promoters.
###end article-title 129
###begin article-title 130
Major histocompatibility class II transactivator (CIITA) mediates repression of collagen (COL1A2) transcription by interferon gamma (IFN-gamma).
###end article-title 130
###begin article-title 131
Regulation of MHC class II gene expression by the class II transactivator.
###end article-title 131
###begin article-title 132
Maturation of dendritic cells is accompanied by rapid transcriptional silencing of class II transactivator (CIITA) expression.
###end article-title 132
###begin article-title 133
RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency.
###end article-title 133
###begin article-title 134
###xml 108 116 <span type="species:ncbi:9606">patients</span>
A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients.
###end article-title 134
###begin article-title 135
A novel DNA binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome).
###end article-title 135
###begin article-title 136
RFX-B is the gene responsible for the most common cause of the bare lymphocyte syndrome, an MHC class II immunodeficiency.
###end article-title 136
###begin article-title 137
Mutation in a winged-helix DNA-binding motif causes atypical bare lymphocyte syndrome.
###end article-title 137
###begin article-title 138
Promoter-specific functions of CIITA and the MHC class II enhancesosome in transcriptional activation.
###end article-title 138
###begin article-title 139
Chromatin remodeling and extragenic transcription at the MHC class II locus control region.
###end article-title 139
###begin article-title 140
Expression of RAB4B, a protein governing endocytic recycling, is co-regulated with MHC class II genes.
###end article-title 140
###begin article-title 141
CIITA coordinates multiple histone acetylation modifications at the HLA- DRA promoter.
###end article-title 141
###begin article-title 142
Statistics for ChIP-chip and DNase hypersensitivity experiments on NimbleGen arrays.
###end article-title 142
###begin article-title 143
Transcription-coupled deposition of histone modifications during MHC class II gene activation.
###end article-title 143
###begin article-title 144
Long distance control of MHC class II expression by multiple distal enhancers regulated by regulatory factor X complex and CIITA.
###end article-title 144
###begin article-title 145
X box-like sequences in the MHC class II region maintain regulatory function.
###end article-title 145
###begin article-title 146
Sp1- and Kruppel-like transcription factors.
###end article-title 146
###begin article-title 147
Rab GTPases: specifying and deciphering organelle identity and function.
###end article-title 147
###begin article-title 148
The many roads to cross-presentation.
###end article-title 148
###begin article-title 149
Cellular mechanisms governing cross-presentation of exogenous antigens.
###end article-title 149
###begin article-title 150
Cell surface recycling of internalized antigen permits dendritic cell priming of B cells.
###end article-title 150
###begin article-title 151
Antigen presentation mediated by recycling of surface HLA-DR molecules.
###end article-title 151
###begin article-title 152
The monomeric guanosine triphosphatase rab4 controls an essential step on the pathway of receptor-mediated antigen processing in B cells.
###end article-title 152
###begin article-title 153
Tripeptidyl-peptidase I in health and disease.
###end article-title 153
###begin article-title 154
The proteasome and MHC class I antigen processing.
###end article-title 154
###begin article-title 155
###xml 21 26 <span type="species:ncbi:9606">human</span>
Complete sequence of human fast-type and slow-type muscle myosin-binding-protein C (MyBP-C). Differential expression, conserved domain structure and chromosome assignment.
###end article-title 155
###begin article-title 156
Cardiac myosin binding protein C: its role in physiology and disease.
###end article-title 156
###begin article-title 157
The actin-based motor protein myosin II regulates MHC class II trafficking and BCR-driven antigen presentation.
###end article-title 157
###begin article-title 158
Enhanced dendritic cell antigen capture via toll-like receptor-induced actin remodeling.
###end article-title 158
###begin article-title 159
Visualization of antigen presentation by actin-mediated targeting of glycolipid-enriched membrane domains to the immune synapse of B cell APCs.
###end article-title 159
###begin article-title 160
TRIM/RBCC, a novel class of single protein RING finger E3 ubiquitin ligases.
###end article-title 160
###begin article-title 161
Epigenetic silencing of MHC2TA transcription in cancer.
###end article-title 161
###begin article-title 162
Tumour immunology, vaccination and escape strategies.
###end article-title 162
###begin article-title 163
Revisiting the specificity of the MHC class II transactivator CIITA in vivo.
###end article-title 163
###begin article-title 164
Keeping transcriptional activators under control.
###end article-title 164
###begin article-title 165
CATERPILLER: a novel gene family important in immunity, cell death, and diseases.
###end article-title 165
###begin article-title 166
NOD-LRR proteins: role in host-microbial interactions and inflammatory disease.
###end article-title 166
###begin article-title 167
NLRs join TLRs as innate sensors of pathogens.
###end article-title 167
###begin article-title 168
Nouvelles recherches sur distribution florale.
###end article-title 168
###begin article-title 169
Finding Groups in Data: An Introduction to Cluster Analysis.
###end article-title 169
###begin article-title 170
Silhouettes: a graphical aid to the interpretation and validation of cluster analysis.
###end article-title 170
###begin p 171
The authors have declared that no competing interests exist.
###end p 171
###begin p 172
This work was supported by contributions from the Swiss National Science Foundation, the Geneva Cancer League, the Swiss Multiple Sclerosis Society and the National Center of Competence in Research on Neural Plasticity and Repair (NCCR-NEURO).
###end p 172

